Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Early diagnoses for Duchenne
Hope for newly diagnosed DMD
CureDuchenne-Research-banner-mobile
Stay Informed
Find Out What’s New in Duchenne Research
CD Research Desktop
Stay Informed
Find Out What’s New in Duchenne Research
CD Links
CD LINK Logo
CD LINK Logo
Linking the Community to a Cure
early diagnosis
CureDuchenne logo white
Making Earlier Diagnosis a Reality with Newborn Screening
CureDuchenne has partnered with Brigham & Women’s Hospital to offer the first supplemental newborn screening for Duchenne in a clinical setting.
great hope
There is Great Hope for Duchenne!
Newly Diagnosed Families, Get the Help You Need!
2025 FUTURES Homepage Slider Banner_mobile
2025 FUTURES Homepage Slider Banner_full
previous arrow
next arrow

With a mission to cure Duchenne muscular dystrophy

CureDuchenne breaks the traditional charitable mold and balances passion with business acumen. We will fulfill our mission to cure Duchenne muscular dystrophy with our innovative venture philanthropy model that funds groundbreaking research, early diagnosis and treatment access. With pioneering education and support programs, our organization drives real change for those with living with the disease and their loved ones.

The CureDuchenne one-to-one program provides meetings with our scientists, physical therapists, parents, fundraising team and family support resource coordinators. Email us at Cares@CureDuchenne.org to set up a time that works with your schedule. Together we will cure Duchenne muscular dystrophy!

Making an Impact on Duchenne

Accelerating Curative treatments


 

10


Since the inception of CureDuchenne, life expectancy for Duchenne has increased by a decade.

Funding Critical Clinical Trials


 

18


18 projects funded by CureDuchenne have progressed to clinical trials.

Making an Impact


 

$50+M


We’ve raised over $50 million for research, education and care.

Accelerating a Cure


 

1st


CureDuchenne contributed early funding for the first FDA-approved Duchenne drug.

Working Towards the Future


 

$3B


Our model has leveraged over $3 billion in follow-on funding for future programs from investors and biotech companies.

Working towards a cure for Duchenne

Duchenne is a devastating muscle disease.

Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy, occurring in approximately 1:5,000 male births. Those affected with DMD lose their ability to walk, feed themselves, breathe independently and succumb to heart failure.

But there’s hope through new pharmacological and gene-based therapies. You can help make a difference in finding a cure.

LATEST DUCHENNE NEWS & UPCOMING EVENTS